Tapewire

Nasdaq · USD

TARS

Tarsus Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
1836
SEC CIK
0001819790
Parsed reports
328

Last 12 months

Inside the activity.

0 purchase rows · 59 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202509
Jan 202604
Feb 202600
Mar 2026026
Apr 202600
May 202600
Jun 202606
Jul 202600
Aug 202600
Sep 2026014
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 04, 2025 Filed Dec 8, 2025 21:06 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
GiftCommon Stock 51,885 $0.00 $0.00
Disclosure

SEC source: 0001827672-25-000005 · wk-form4_1765227987.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,750

F1 · ownership.direct: The Reporting Person transferred 51,885 shares of common stock to the Bobak Azamian Living Trust for no consideration. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
September 24, 2025 Filed Sep 26, 2025 20:08 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 6,000 $55.37 $332,220.00
Disclosure

SEC source: 0001827672-25-000003 · wk-form4_1758917331.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 812,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $55.19 to $55.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
September 16, 2025 Filed Sep 18, 2025 21:00 UTC GiftCommon Stock 2,000 $0.00 $0.00
Disclosure

SEC source: 0001228684-25-000003 · wk-form4_1758229231.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 141,332

Read SEC document
September 15, 2025 Filed Sep 16, 2025 20:06 UTC Exercise / conversionRestricted Stock Units · Derivative 1,334 $0.00 $0.00
Disclosure

SEC source: 0001662426-25-000005 · wk-form4_1758053184.xml · derivative · entry 3

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,334 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.

F3 · derivative.expiration_date: The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service.

Read SEC document
September 15, 2025 Filed Sep 16, 2025 20:06 UTC Exercise / conversionCommon Stock 1,334 Not disclosed Not disclosed
Disclosure

SEC source: 0001662426-25-000005 · wk-form4_1758053184.xml · nonDerivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
September 08, 2025 Filed Sep 10, 2025 21:03 UTC SaleCommon Stock 27,116 $57.00 $1,545,612.00
Disclosure

SEC source: 0001819790-25-000113 · wk-form4_1757538213.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 143,332

F1 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $56.66 to $57.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 20:32 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 6,000 $50.00 $300,000.00
Disclosure

SEC source: 0001819790-25-000110 · wk-form4_1755117154.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: Plan reported

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 818,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.

F2 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
June 17, 2025 Filed Jun 18, 2025 20:07 UTC
Farrow Jeffrey SSee Remarks
SaleCommon Stock 13,608 $40.42 $550,035.36
Disclosure

SEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · nonDerivative · entry 2

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,704

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 17, 2025 20:07 UTC
Lin Elizabeth YeuChief Medical Officer
SaleCommon Stock 1,006 $41.08 $41,326.48
Disclosure

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 2

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,694

F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 20:07 UTC
Farrow Jeffrey SSee Remarks
Exercise / conversionRestricted Stock Units · Derivative 27,881 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · derivative · entry 3

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,763

Underlying: Common Stock · 27,881 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

F4 · derivative.expiration_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service.

Read SEC document
June 16, 2025 Filed Jun 18, 2025 20:07 UTC
Farrow Jeffrey SSee Remarks
Exercise / conversionCommon Stock 27,881 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · nonDerivative · entry 1

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,312

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:05 UTC Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 4

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:05 UTC Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · nonDerivative · entry 1

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 4

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · nonDerivative · entry 1

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 4

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · nonDerivative · entry 1

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 5

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:04 UTC Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · nonDerivative · entry 1

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,350

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:03 UTC Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 5

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F6 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F6 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:03 UTC Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · nonDerivative · entry 1

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,448

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:07 UTC
Lin Elizabeth YeuChief Medical Officer
Exercise / conversionRestricted Stock Units · Derivative 3,350 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · derivative · entry 5

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,350 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 13, 2025 Filed Jun 17, 2025 20:07 UTC
Lin Elizabeth YeuChief Medical Officer
Exercise / conversionCommon Stock 3,350 Not disclosed Not disclosed
Disclosure

SEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 1

Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,700

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:05 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000093 · wk-form4_1750104304.xml · derivative · entry 2

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:05 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000093 · wk-form4_1750104304.xml · derivative · entry 1

Goodrich Katherine · CIK 0002044770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:05 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 3

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:05 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 2

CHAUDHURI BHASKAR · CIK 0001458643 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 3

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 2

Goldberg Andrew D. · CIK 0001827722 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 3

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 2

YARNO WENDY L · CIK 0001181186 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 4

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:04 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 3

Morrison Scott W · CIK 0001662426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:03 UTC GrantRestricted Stock Units · Derivative 2,954 $0.00 $0.00
Disclosure

SEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 4

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,954

Underlying: Common Stock · 2,954 shares

Expires not disclosed

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F5 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

F5 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 12, 2025 Filed Jun 16, 2025 20:03 UTC GrantStock Option (right to buy) · Derivative 4,540 $0.00 Strike: $40.95 $0.00
Disclosure

SEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 3

LINK WILLIAM J PHD · CIK 0001228684 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,540

Underlying: Common Stock · 4,540 shares

Expires 2035-06-11

F3 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Read SEC document
June 09, 2025 Filed Jun 11, 2025 20:50 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 17,500 $43.76 $765,800.00
Disclosure

SEC source: 0001819790-25-000081 · wk-form4_1749675042.xml · nonDerivative · entry 1

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 47,557

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025.

F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $43.42 to $44.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 20:47 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 6,000 $50.00 $300,000.00
Disclosure

SEC source: 0001819790-25-000061 · wk-form4_1743022033.xml · nonDerivative · entry 1

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018

Disclosed balance after: 824,106

F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.

F2 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:49 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 3,365 $50.11 $168,620.15
Disclosure

SEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 3

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,057

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:49 UTC
Wahl BryanGeneral Counsel
SaleCommon Stock 3,084 $50.11 $154,539.24
Disclosure

SEC source: 0001819790-25-000057 · wk-form4_1742521746.xml · nonDerivative · entry 3

Wahl Bryan · CIK 0001841401 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,712

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:49 UTC
Neervannan SeshadriChief Operating Officer
SaleCommon Stock 2,435 $50.11 $122,017.85
Disclosure

SEC source: 0001819790-25-000058 · wk-form4_1742521768.xml · nonDerivative · entry 3

Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,682

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:48 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 8,534 $50.11 $427,638.74
Disclosure

SEC source: 0001819790-25-000055 · wk-form4_1742521708.xml · nonDerivative · entry 3

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,635

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:48 UTC
Whitfield Dianne C.Chief Human Resources Officer
SaleCommon Stock 2,137 $50.11 $107,085.07
Disclosure

SEC source: 0001819790-25-000056 · wk-form4_1742521727.xml · nonDerivative · entry 3

Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,355

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 20, 2025 Filed Mar 21, 2025 01:48 UTC
Farrow Jeffrey SSee Remarks
SaleCommon Stock 1,186 $50.11 $59,430.46
Disclosure

SEC source: 0001819790-25-000054 · wk-form4_1742521688.xml · nonDerivative · entry 3

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,431

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:49 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 3,557 $47.40 $168,601.80
Disclosure

SEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 2

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,422

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:49 UTC
Wahl BryanGeneral Counsel
SaleCommon Stock 3,261 $47.40 $154,571.40
Disclosure

SEC source: 0001819790-25-000057 · wk-form4_1742521746.xml · nonDerivative · entry 2

Wahl Bryan · CIK 0001841401 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,796

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:49 UTC
Neervannan SeshadriChief Operating Officer
SaleCommon Stock 2,543 $47.40 $120,538.20
Disclosure

SEC source: 0001819790-25-000058 · wk-form4_1742521768.xml · nonDerivative · entry 2

Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,117

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:48 UTC
Azamian Bobak R.Director · President/CEO and Board Chair
SaleCommon Stock 8,551 $47.40 $405,317.40
Disclosure

SEC source: 0001819790-25-000055 · wk-form4_1742521708.xml · nonDerivative · entry 2

Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,169

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:48 UTC
Whitfield Dianne C.Chief Human Resources Officer
SaleCommon Stock 2,259 $47.40 $107,076.60
Disclosure

SEC source: 0001819790-25-000056 · wk-form4_1742521727.xml · nonDerivative · entry 2

Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,492

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 19, 2025 Filed Mar 21, 2025 01:48 UTC
Farrow Jeffrey SSee Remarks
SaleCommon Stock 1,254 $47.40 $59,439.60
Disclosure

SEC source: 0001819790-25-000054 · wk-form4_1742521688.xml · nonDerivative · entry 2

Farrow Jeffrey S · CIK 0001405253 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,617

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document
March 18, 2025 Filed Mar 21, 2025 01:49 UTC
Mottiwala AzizChief Commercial Officer
SaleCommon Stock 3,643 $46.29 $168,634.47
Disclosure

SEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 1

Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,979

F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.